Loading...

SOHO 2026 Annual Meeting

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.

1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

ePostersLive by SciGen Technologies S.A. All rights reserved.

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Home Posters by Code Posters by Title Authors Affiliations Topics Sessions Videos Audios Previous meetings

Topics

Select Topic

Showing 102 results for "Myeloproliferative Neoplasms (MPN)".

Thumbnail for Cardiovascular Risk Burden and Thrombotic Outcomes in Essential Thrombocythemia: A 152-Patient Real-World Cohort with 8.6-Year Median Follow-Up

MPN - 821

Cardiovascular Risk Burden and Thrombotic Outcomes in Essential Thrombocythemia: A 152-Patient Real-World Cohort with 8.6-Year Median Follow-Up

Elmir Israfilov

Poster Presenter: Elmir Israfilov

Thumbnail for Update From the Phase 2 RESTORE Trial of Elritercept in Patients With Myelofibrosis Receiving Ruxolitinib

MPN - 832

Update From the Phase 2 RESTORE Trial of Elritercept in Patients With Myelofibrosis Receiving Ruxolitinib

Ciro Rinaldi

Poster Presenter: Ciro Rinaldi

Previous 1...8 9 10 11 12 Next

Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

Thumbnail for In-Hospital Mortality and 30-Day Readmissions in Patients With Myeloproliferative Neoplasm Hospitalized With NSTEMI: A Nationwide Analysis Stratified by Revascularization Strategy

MPN - 847

In-Hospital Mortality and 30-Day Readmissions in Patients With Myeloproliferative Neoplasm Hospitalized With NSTEMI: A Nationwide Analysis Stratified by Revascularization Strategy

Aishwarya Ramesh

Poster Presenter: Aishwarya Ramesh

Thumbnail for Clinical and Molecular Features of Adult-Onset KRAS-Mutant Leukoproliferative Disorder With Monocytosis

MPN - 850

Clinical and Molecular Features of Adult-Onset KRAS-Mutant Leukoproliferative Disorder With Monocytosis

Emma St Martin

Poster Presenter: Emma St Martin

Thumbnail for Efficacy of Midostaurin Therapy and Allogeneic Bone Marrow Transplantation in Patients With Advanced Systemic Mastocytosis

MPN - 855

Efficacy of Midostaurin Therapy and Allogeneic Bone Marrow Transplantation in Patients With Advanced Systemic Mastocytosis

Zarema Abdulkhalikova

Poster Presenter: Zarema Abdulkhalikova

Thumbnail for Urinary Mast Cell Metabolites Versus Serum Tryptase for Monitoring Clinical Response to Cytoreductive Therapy in Indolent Systemic Mastocytosis

MPN - 861

Urinary Mast Cell Metabolites Versus Serum Tryptase for Monitoring Clinical Response to Cytoreductive Therapy in Indolent Systemic Mastocytosis

Cecilia Arana-Yi

Poster Presenter: Cecilia Arana-Yi

Thumbnail for Upfront Pemigatinib for Chronic-Phase Myeloid/Lymphoid Neoplasm with a Novel FGFR1 Rearrangement Presenting as Transient Bilateral Vision Loss: A Case Report.

MPN - 875

Upfront Pemigatinib for Chronic-Phase Myeloid/Lymphoid Neoplasm with a Novel FGFR1 Rearrangement Presenting as Transient Bilateral Vision Loss: A Case Report.

Jorge Sanchez Orbe

Poster Presenter: Jorge Sanchez Orbe

Thumbnail for Modulation of the Hepcidin Pathway Produces Homogeneous Erythropoietic Suppression but Heterogeneous Iron Repletion in Polycythemia Vera: Lessons from REVIVE and IMPRSSION.

MPN - 908

Modulation of the Hepcidin Pathway Produces Homogeneous Erythropoietic Suppression but Heterogeneous Iron Repletion in Polycythemia Vera: Lessons from REVIVE and IMPRSSION.

Ashiya Loomba

Poster Presenter: Ashiya Loomba

Thumbnail for Efficacy and Molecular Dynamics of Ropeginterferon Alfa-2b in High-Risk Essential Thrombocythemia: 2-Year Results from the Phase 3 SURPASS-ET Trial

MPN - 944

Efficacy and Molecular Dynamics of Ropeginterferon Alfa-2b in High-Risk Essential Thrombocythemia: 2-Year Results from the Phase 3 SURPASS-ET Trial

Lucia Masarova

Poster Presenter: Lucia Masarova

ePosters in

Topics Sessions

Acute Lymphoblastic Leukemia (ALL)(71)Acute Myeloid Leukemia (AML)(230)Aggressive B-Cell Lymphoma (ABCL)(114)Cellular Therapy (CT)(128)Chronic Lymphocytic Leukemia (CLL)(110)Chronic Myeloid Leukemia (CML)(55)Hodgkin Lymphoma (HL)(54)Indolent B-Cell Lymphoma (IBCL)(47)Mantle Cell Lymphoma (MCL)(23)Multiple Myeloma (MM)(234)

Previous 1 2 Next

Sponsors